Caribou Bioscience’s CEO on CRISPR’s legal and ethical challenges

 Caribou Bioscience co-founder and CEO Rachel Haurwitz joined us onstage at Disrupt this morning to help unpack some of the myriad complexities around her company’s pioneering work in the field of CRISPR biology. The gene editing tool has been the source of tremendous excitement over the last several years for its potential to help science hack everything from disease to food supply.… Read More

Scroll to top